Potentiating TMEM16A does not stimulate airway mucus secretion or bronchial and pulmonary arterial smooth muscle contraction.

Anoctamin‐1 ETX001 bronchoconstriction mucin vasoconstriction

Journal

FASEB bioAdvances
ISSN: 2573-9832
Titre abrégé: FASEB Bioadv
Pays: United States
ID NLM: 101733210

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 11 05 2020
revised: 11 05 2020
accepted: 10 06 2020
entrez: 22 8 2020
pubmed: 22 8 2020
medline: 22 8 2020
Statut: epublish

Résumé

The calcium-activated chloride channel (CaCC) TMEM16A enables chloride secretion across several transporting epithelia, including in the airways. Additional roles for TMEM16A have been proposed, which include regulating mucus production and secretion and stimulating smooth muscle contraction. The aim of the present study was to test whether the pharmacological regulation of TMEM16A channel function, could affect any of these proposed biological roles in the airways. In vitro, neither a potent and selective TMEM16A potentiator (ETX001) nor the potent TMEM16A inhibitor (Ani9) influenced either baseline mucin release or goblet cell numbers in well-differentiated primary human bronchial epithelial (HBE) cells. In vivo, a TMEM16A potentiator was without effect on goblet cell emptying in an IL-13 stimulated goblet cell metaplasia model. Using freshly isolated human bronchi and pulmonary arteries, neither ETX001 or Ani9 had any effect on the contractile or relaxant responses of the tissues. In vivo, ETX001 also failed to influence either lung or cardiovascular function when delivered directly into the airways of telemetered rats. Together, these studies do not support a role for TMEM16A in the regulation of goblet cell numbers or baseline mucin release, or on the regulation of airway or pulmonary artery smooth muscle contraction.

Identifiants

pubmed: 32821878
doi: 10.1096/fba.2020-00035
pii: FBA21148
pmc: PMC7429354
doi:

Types de publication

Journal Article

Langues

eng

Pagination

464-477

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL129795
Pays : United States

Informations de copyright

© 2020 Enterprise Therapeutics Ltd.

Déclaration de conflit d'intérêts

All work has been funded by Enterprise Therapeutics Ltd. HD, SPC, and MG are full‐time employees of Enterprise Therapeutics Ltd.

Références

Nat Med. 2014 Nov;20(11):1263-9
pubmed: 25282357
Int J Biochem Cell Biol. 2012 Nov;44(11):1897-900
pubmed: 22710346
Exp Cell Res. 2015 Jun 10;334(2):260-9
pubmed: 25770012
Cell Rep. 2015 Jan 13;10(2):239-52
pubmed: 25558064
JCI Insight. 2019 Mar 21;4(6):
pubmed: 30721150
PLoS One. 2016 May 24;11(5):e0155771
pubmed: 27219012
Cell. 2008 Sep 19;134(6):1019-29
pubmed: 18805094
Methods Mol Med. 2005;107:183-206
pubmed: 15492373
Front Pharmacol. 2019 Jan 29;10:3
pubmed: 30761000
Allergy Asthma Immunol Res. 2015 Jul;7(4):367-75
pubmed: 25749771
J Cyst Fibros. 2015 Sep;14(5):561-70
pubmed: 26115565
Am J Respir Cell Mol Biol. 2004 Oct;31(4):382-94
pubmed: 15191915
Am J Respir Crit Care Med. 2020 Apr 15;201(8):946-954
pubmed: 31898911
Br J Pharmacol. 2015 Jun;172(11):2814-26
pubmed: 25573195
Pflugers Arch. 2010 Mar;459(4):579-92
pubmed: 19888597
Front Pharmacol. 2019 Feb 14;10:51
pubmed: 30837866
Am J Physiol Lung Cell Mol Physiol. 2020 Feb 1;318(2):L287-L295
pubmed: 31747299
FASEB J. 2011 Nov;25(11):4048-62
pubmed: 21836025
Mol Pharmacol. 1994 Oct;46(4):750-3
pubmed: 7969055
Genome Res. 2001 Sep;11(9):1473-83
pubmed: 11544191
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16354-9
pubmed: 22988107
Nature. 2002 May 23;417(6887):447-52
pubmed: 12024214
Science. 2008 Oct 24;322(5901):590-4
pubmed: 18772398
Am J Respir Cell Mol Biol. 1993 Sep;9(3):315-22
pubmed: 8398169
Br J Pharmacol. 2015 Aug;172(16):4158-72
pubmed: 26013995
Pulm Circ. 2015 Jun;5(2):244-68
pubmed: 26064450
J Physiol. 2019 Dec;597(24):5859-5878
pubmed: 31622498
FASEB J. 2019 Mar;33(3):4502-4512
pubmed: 30586313
Nature. 2008 Oct 30;455(7217):1210-5
pubmed: 18724360
Toxicology. 2014 Oct 3;324:136-46
pubmed: 25108121
J Biol Chem. 2007 Nov 16;282(46):33247-51
pubmed: 17911111
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16528-33
pubmed: 23012413
Physiol Rev. 2014 Apr;94(2):419-59
pubmed: 24692353
Am J Physiol Cell Physiol. 2002 Dec;283(6):C1637-45
pubmed: 12388058
Int J Biochem Cell Biol. 2014 Jul;52:73-6
pubmed: 24704530
Anesthesiology. 2015 Sep;123(3):569-81
pubmed: 26181339
Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L730-9
pubmed: 12794003
PLoS One. 2015 May 29;10(5):e0127267
pubmed: 26024524
J Physiol. 2012 Dec 1;590(23):6141-55
pubmed: 22988141
Int Immunopharmacol. 2016 Nov;40:106-114
pubmed: 27588910
Mol Membr Biol. 2004 Jan-Feb;21(1):27-38
pubmed: 14668136
Life Sci Alliance. 2019 Nov 15;2(6):
pubmed: 31732694

Auteurs

Henry Danahay (H)

Enterprise Therapeutics Ltd, Science Park Square Brighton UK.

Roy Fox (R)

School of Life Sciences University of Sussex Brighton UK.

Sarah Lilley (S)

School of Life Sciences University of Sussex Brighton UK.

Holly Charlton (H)

School of Life Sciences University of Sussex Brighton UK.

Kathryn Adley (K)

School of Life Sciences University of Sussex Brighton UK.

Lee Christie (L)

REPROCELL Europe Ltd, West of Scotland Science Park Glasgow UK.

Ejaz Ansari (E)

REPROCELL Europe Ltd, West of Scotland Science Park Glasgow UK.

Camille Ehre (C)

Marsico Lung Institute University of North Carolina Chapel Hill NC USA.

Alexis Flen (A)

Marsico Lung Institute University of North Carolina Chapel Hill NC USA.

Michael J Tuvim (MJ)

Department of Pulmonary Medicine The University of Texas MD Anderson Cancer Center Houston TX USA.

Burton F Dickey (BF)

Department of Pulmonary Medicine The University of Texas MD Anderson Cancer Center Houston TX USA.

Colin Williams (C)

Covance Laboratories Ltd Huntingdon UK.

Sarah Beaudoin (S)

Covance Laboratories Ltd Huntingdon UK.

Stephen P Collingwood (SP)

Enterprise Therapeutics Ltd, Science Park Square Brighton UK.

Martin Gosling (M)

Enterprise Therapeutics Ltd, Science Park Square Brighton UK.
School of Life Sciences University of Sussex Brighton UK.

Classifications MeSH